< 1 minute read
Oct. 6, 2021

TAK-020: A Highly Selective Oral Covalent BTK Inhibitor

TAK-020

oral covalent BTK inhibitor >80% BTK occupancy <5 mg (Ph. I dose esc.) from fragment-based screen of 11k cmpds Journal of Medicinal Chemistry Takeda, San Diego, CA, USA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in